Saif ur Rahman Compares K2 and K3 EDTA: Key Differences Explained
Saif ur Rahman, Trainee Medical laboratory technologist at Shaukat Khanum Memorial Cancer Hospital and Research Centre, shared on LinkedIn:
”K2 EDTA vs K3 EDTA – Key Differences Explained
Choosing the correct EDTA tube is critical for accurate hematology results.
Here’s a simple breakdown every lab professional should know
1. Chemical Composition
K2 EDTA → Dipotassium EDTA
K3 EDTA → Tripotassium EDTA
Both act as anticoagulants by binding calcium, preventing clot formation.
2. Additive Form
K2 EDTA → Spray-dried powder
K3 EDTA → Liquid additive
Liquid K3 EDTA can slightly dilute the blood sample.
3. Effect on Blood Cells
K2 EDTA
• Better preservation of cell morphology
• Accurate RBC, WBC and platelet counts
K3 EDTA
• May cause cell shrinkage
• Can affect MCV and hematocrit values
4. Dilution Effect
K2 EDTA → Minimal dilution
K3 EDTA → Slight dilution (due to liquid form)
5. Preferred Laboratory Use
K2 EDTA Gold standard for Routine CBC and Hematology
K3 EDTA
Used for general CBC / rapid testing
Summary
K2 EDTA → Better cell preservation and reliable CBC results
K3 EDTA → Faster anticoagulation but minor dilution effects
Most modern laboratories prefer K2 EDTA for routine hematology.
Lab Tip
Correct tube selection equals accurate results plus better patient care”

Stay updated with Hemostasis Today.
-
Jan 30, 2026, 10:22Manpreet Gill on Heparin Resistance: When 14 Years of Experience Finally Gets a Plot Twist
-
Jan 30, 2026, 10:14Mohamed Elsaid on The Role of Hyperlipidemia in Thrombogenesis
-
Jan 30, 2026, 09:57From Risk Visualization to Plaque Change: Babak Alex Vakili on CAC and CCTA Insights
-
Jan 29, 2026, 14:02Emma Lefrancais on Alarmin IL33 and Platelet Biology
-
Jan 29, 2026, 13:44Sia A: One of My Favorite Conversations from ASH
-
Jan 29, 2026, 13:34Sarah Matuja on Tanzania Stroke Project
-
Jan 29, 2026, 13:28Nancy Di Salvo on Amplifying Rare Disease Voices Through Partnership
-
Jan 29, 2026, 13:21Raul Santos Shares The Results of ORION-16: On The Efficacy and Safety of Inclisiran
-
Jan 29, 2026, 05:22Aravind Palraj Draws a Comparison Between APS and Lupus Cerebritis
